Q2 2023 Holdings
Filed 2023-08-14 | 93 holdings | $2.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $15.0K | 90,560 | 0.0% |
| Arteris Inc(AIP) | COM | 04302A104 | $514.9K | 75,500 | 0.0% |
| Exscientia PLC | ADS | 30223G102 | $755.4K | 127,600 | 0.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $1.6M | 37,800 | 0.1% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $1.7M | 215,100 | 0.1% |
| Caremax Inc | COM CL A | 14171W103 | $2.0M | 636,000 | 0.1% |
| Simulations Plus Inc(SLP) | COM | 829214105 | $2.0M | 45,900 | 0.1% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $2.6M | 1,188,178 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $3.5M | 1,110,900 | 0.1% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $4.1M | 1,174,100 | 0.1% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $4.6M | 1,464,034 | 0.2% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $5.1M | 1,738,734 | 0.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $5.2M | 1,620,200 | 0.2% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $5.4M | 2,765,500 | 0.2% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $5.6M | 657,200 | 0.2% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $7.1M | 393,000 | 0.2% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $7.6M | 354,100 | 0.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $8.3M | 282,752 | 0.3% |
| AC Immune SA(ACIU) | SHS | H00263105 | $8.6M | 2,903,278 | 0.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $10.0M | 526,376 | 0.3% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $10.2M | 175,000 | 0.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $10.9M | 1,058,500 | 0.4% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $10.9M | 2,700,400 | 0.4% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $11.7M | 2,758,600 | 0.4% |
| Mersana Therapeutics Inc | COM | 59045L106 | $12.5M | 3,790,000 | 0.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $13.1M | 766,700 | 0.5% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $13.6M | 1,342,000 | 0.5% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $13.7M | 274,900 | 0.5% |
| Kezar Life Sciences Inc | COM | 49372L100 | $14.9M | 6,080,000 | 0.5% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $15.0M | 8,370,100 | 0.5% |
| Point Biopharma Global Inc | COM | 730541109 | $15.1M | 1,671,800 | 0.5% |
| Acelyrin Inc | COM | 00445A100 | $15.7M | 750,000 | 0.5% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $15.9M | 501,200 | 0.6% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $16.1M | 395,855 | 0.6% |
| Verve Therapeutics Inc | COM | 92539P101 | $16.5M | 878,600 | 0.6% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $16.6M | 916,600 | 0.6% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $17.0M | 1,687,500 | 0.6% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $17.8M | 24,800 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $18.5M | 481,300 | 0.6% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $19.2M | 379,700 | 0.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $19.4M | 901,400 | 0.7% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $20.2M | 954,500 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $20.4M | 400,000 | 0.7% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $20.6M | 245,100 | 0.7% |
| Natera Inc(NTRA) | COM | 632307104 | $21.1M | 432,900 | 0.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $22.7M | 692,500 | 0.8% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $24.7M | 3,000,000 | 0.9% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $26.2M | 415,000 | 0.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $26.3M | 1,326,000 | 0.9% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $26.6M | 5,700,000 | 0.9% |